Sonic Healthcare Limited
SHL
Rank in Stocks
#2859
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Share Price
$13.16
Market Cap
$6.51B
Change (1 day)
0.43%
Change (1 year)
-6.43%
Country
AU
Trade Sonic Healthcare Limited (SHL)
Category
Healthcare
Earnings for Sonic Healthcare Limited (SHL)
Earnings in Jun 2026 TTM: $581.53M
According to Sonic Healthcare Limited latest financial reports the company's current earnings are $581.53M. In 2024 the company made an earning of $487.85M, a decrease compared to its 2023 earnings that were of $620.44M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Sonic Healthcare Limited from 2000 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $581.53M | 17.65% |
| 2025 | $494.30M | 1.32% |
| 2024 | $487.85M | -21.37% |
| 2023 | $620.44M | -56.70% |
| 2022 | $1.43B | 4.50% |
| 2021 | $1.37B | 184.25% |
| 2020 | $482.35M | -4.91% |
| 2019 | $507.24M | 11.00% |
| 2018 | $456.95M | 3.07% |
| 2017 | $443.36M | -0.42% |
| 2016 | $445.22M | 24.81% |
| 2015 | $356.72M | -26.56% |
| 2014 | $485.74M | 19.92% |
| 2013 | $405.04M | -5.17% |
| 2012 | $427.14M | 2.04% |
| 2011 | $418.61M | 27.85% |
| 2010 | $327.42M | 62.12% |
| 2009 | $201.96M | -36.56% |
| 2008 | $318.35M | 29.08% |
| 2007 | $246.63M | 25.90% |
| 2006 | $195.89M | 69.95% |
| 2005 | $115.26M | 60.97% |
| 2004 | $71.61M | 36.20% |
| 2003 | $52.57M | 41.85% |
| 2002 | $37.06M | 31.08% |
| 2001 | $28.27M | 16.52% |
| 2000 | $24.26M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $7.61B | 1,208.44% |
US
|
|
| $4.76B | 718.87% |
US
|
|
| $-252.70M | -143.45% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 185.11% |
US
|
